Form 4 for KLRS Kalaris Therapeutics, Inc.
Accepted 2026-03-23 00:00:00 ET · period of report 2026-03-19 · accession 0001193125-26-119707 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-23 | 2026-03-20 | KLRS | Hagen Brett R | CAO | S - Sale | $6.72 | -1,915 | 0 | -100% | -$12.9K |
| D | 2026-03-23 | 2026-03-19 | KLRS | Hagen Brett R | CAO | A - Grant | $0.00 | +60.8K | 60.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-20 | S | D | 1,915 | $6.72 | 0 | D | — | — | (F1) Due to an administrative error, the Reporting Person filed a Form 4 on March 27, 2025 reporting beneficial ownership of 1,925 shares, when in fact the amount of securities beneficially owned was 1,915. The number of shares beneficially owned by the Reporting Person following the transaction reported herein has been updated accordingly. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-03-19 | A | A | 60,800 | $0.00 | 60,800 | D | $6.81 · — to 2036-03-18 | 60,800 Common Stock | (F2) The option was granted on March 19, 2026. The shares underlying the option are scheduled to vest over four years, with 25% of the shares underlying the option vesting on March 19, 2027, and the remainder vesting in equal monthly installments thereafter, subject to continuous service. |